BASTEI LUBBE AG (BST.DE) Fundamental Analysis & Valuation

FRA:BSTDE000A1X3YY0

Current stock price

6.62 EUR
-0.06 (-0.9%)
Last:

This BST.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BST.DE Profitability Analysis

1.1 Basic Checks

  • BST had positive earnings in the past year.
  • In the past year BST has reported a negative cash flow from operations.
  • In the past 5 years BST has always been profitable.
  • BST had a positive operating cash flow in 4 of the past 5 years.
BST.DE Yearly Net Income VS EBIT VS OCF VS FCFBST.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

1.2 Ratios

  • BST has a better Return On Assets (7.78%) than 92.31% of its industry peers.
  • BST's Return On Equity of 13.88% is fine compared to the rest of the industry. BST outperforms 78.46% of its industry peers.
  • BST has a better Return On Invested Capital (11.80%) than 87.69% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BST is above the industry average of 7.84%.
  • The 3 year average ROIC (11.74%) for BST is below the current ROIC(11.80%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.78%
ROE 13.88%
ROIC 11.8%
ROA(3y)7.31%
ROA(5y)8.15%
ROE(3y)12.63%
ROE(5y)15.01%
ROIC(3y)11.74%
ROIC(5y)11.8%
BST.DE Yearly ROA, ROE, ROICBST.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • The Profit Margin of BST (8.23%) is better than 81.54% of its industry peers.
  • In the last couple of years the Profit Margin of BST has declined.
  • BST has a Operating Margin of 11.41%. This is in the better half of the industry: BST outperforms 70.77% of its industry peers.
  • BST's Operating Margin has improved in the last couple of years.
  • BST has a Gross Margin of 51.60%. This is comparable to the rest of the industry: BST outperforms 53.85% of its industry peers.
  • In the last couple of years the Gross Margin of BST has grown nicely.
Industry RankSector Rank
OM 11.41%
PM (TTM) 8.23%
GM 51.6%
OM growth 3Y5.11%
OM growth 5Y25.16%
PM growth 3Y-4.99%
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y3.74%
BST.DE Yearly Profit, Operating, Gross MarginsBST.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

5

2. BST.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BST is still creating some value.
  • The number of shares outstanding for BST remains at a similar level compared to 1 year ago.
  • BST has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BST has an improved debt to assets ratio.
BST.DE Yearly Shares OutstandingBST.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BST.DE Yearly Total Debt VS Total AssetsBST.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • An Altman-Z score of 2.86 indicates that BST is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 2.86, BST belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
  • BST has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.05, BST belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 2.86
ROIC/WACC1.65
WACC7.13%
BST.DE Yearly LT Debt VS Equity VS FCFBST.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • BST has a Current Ratio of 1.46. This is a normal value and indicates that BST is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.46, BST is in the better half of the industry, outperforming 75.38% of the companies in the same industry.
  • A Quick Ratio of 1.07 indicates that BST should not have too much problems paying its short term obligations.
  • BST has a better Quick ratio (1.07) than 67.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.07
BST.DE Yearly Current Assets VS Current LiabilitesBST.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2

3. BST.DE Growth Analysis

3.1 Past

  • The earnings per share for BST have decreased strongly by -10.98% in the last year.
  • Measured over the past 5 years, BST shows a small growth in Earnings Per Share. The EPS has been growing by 1.14% on average per year.
  • Looking at the last year, BST shows a decrease in Revenue. The Revenue has decreased by -0.79% in the last year.
  • Measured over the past years, BST shows a small growth in Revenue. The Revenue has been growing by 6.95% on average per year.
EPS 1Y (TTM)-10.98%
EPS 3Y1.14%
EPS 5YN/A
EPS Q2Q%-32.37%
Revenue 1Y (TTM)-0.79%
Revenue growth 3Y6.45%
Revenue growth 5Y6.95%
Sales Q2Q%3.3%

3.2 Future

  • BST is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.18% yearly.
  • The Revenue is expected to grow by 0.99% on average over the next years.
EPS Next Y-9.69%
EPS Next 2Y0.19%
EPS Next 3Y-1.18%
EPS Next 5YN/A
Revenue Next Year2.05%
Revenue Next 2Y2.22%
Revenue Next 3Y2.2%
Revenue Next 5Y0.99%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BST.DE Yearly Revenue VS EstimatesBST.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M
BST.DE Yearly EPS VS EstimatesBST.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

5

4. BST.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.68, the valuation of BST can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BST indicates a somewhat cheap valuation: BST is cheaper than 69.23% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of BST to the average of the S&P500 Index (25.23), we can say BST is valued rather cheaply.
  • A Price/Forward Earnings ratio of 7.59 indicates a rather cheap valuation of BST.
  • Based on the Price/Forward Earnings ratio, BST is valued a bit cheaper than 80.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, BST is valued rather cheaply.
Industry RankSector Rank
PE 10.68
Fwd PE 7.59
BST.DE Price Earnings VS Forward Price EarningsBST.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • BST's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BST is cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.81
BST.DE Per share dataBST.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The decent profitability rating of BST may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.19%
EPS Next 3Y-1.18%

7

5. BST.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.39%, BST is a good candidate for dividend investing.
  • The stock price of BST dropped by -23.02% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 3.46, BST pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, BST pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.39%

5.2 History

  • The dividend of BST is nicely growing with an annual growth rate of 156.54%!
Dividend Growth(5Y)156.54%
Div Incr Years1
Div Non Decr Years1
BST.DE Yearly Dividends per shareBST.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • 50.46% of the earnings are spent on dividend by BST. This is a bit on the high side, but may be sustainable.
  • BST's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP50.46%
EPS Next 2Y0.19%
EPS Next 3Y-1.18%
BST.DE Yearly Income VS Free CF VS DividendBST.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M
BST.DE Dividend Payout.BST.DE Dividend Payout, showing the Payout Ratio.BST.DE Dividend Payout.PayoutRetained Earnings

BST.DE Fundamentals: All Metrics, Ratios and Statistics

BASTEI LUBBE AG

FRA:BST (3/20/2026, 7:00:00 PM)

6.62

-0.06 (-0.9%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-05
Earnings (Next)07-13
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners39.08%
Ins Owner ChangeN/A
Market Cap88.05M
Revenue(TTM)115.55M
Net Income(TTM)9.42M
Analysts87.5
Price Target12.39 (87.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.39%
Yearly Dividend0.3
Dividend Growth(5Y)156.54%
DP50.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.18%
PT rev (3m)-6.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.32%
EPS NY rev (3m)-3.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 10.68
Fwd PE 7.59
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 1.44
EV/EBITDA 5.81
EPS(TTM)0.62
EY9.37%
EPS(NY)0.87
Fwd EY13.17%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS8.6
BVpS5.1
TBVpS4.6
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.44
Profitability
Industry RankSector Rank
ROA 7.78%
ROE 13.88%
ROCE 17.42%
ROIC 11.8%
ROICexc 12.87%
ROICexgc 14.25%
OM 11.41%
PM (TTM) 8.23%
GM 51.6%
FCFM N/A
ROA(3y)7.31%
ROA(5y)8.15%
ROE(3y)12.63%
ROE(5y)15.01%
ROIC(3y)11.74%
ROIC(5y)11.8%
ROICexc(3y)15.22%
ROICexc(5y)15.52%
ROICexgc(3y)17.65%
ROICexgc(5y)18.64%
ROCE(3y)17.34%
ROCE(5y)17.43%
ROICexgc growth 3Y-3.07%
ROICexgc growth 5Y16.83%
ROICexc growth 3Y1.69%
ROICexc growth 5Y15.18%
OM growth 3Y5.11%
OM growth 5Y25.16%
PM growth 3Y-4.99%
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y3.74%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.24
Cap/Depr 73.65%
Cap/Sales 1.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.07
Altman-Z 2.86
F-Score3
WACC7.13%
ROIC/WACC1.65
Cap/Depr(3y)46.32%
Cap/Depr(5y)34.22%
Cap/Sales(3y)1.19%
Cap/Sales(5y)0.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.98%
EPS 3Y1.14%
EPS 5YN/A
EPS Q2Q%-32.37%
EPS Next Y-9.69%
EPS Next 2Y0.19%
EPS Next 3Y-1.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.79%
Revenue growth 3Y6.45%
Revenue growth 5Y6.95%
Sales Q2Q%3.3%
Revenue Next Year2.05%
Revenue Next 2Y2.22%
Revenue Next 3Y2.2%
Revenue Next 5Y0.99%
EBIT growth 1Y-16.35%
EBIT growth 3Y11.89%
EBIT growth 5Y33.86%
EBIT Next Year-3.75%
EBIT Next 3Y4.01%
EBIT Next 5YN/A
FCF growth 1Y-228.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-193.21%
OCF growth 3YN/A
OCF growth 5YN/A

BASTEI LUBBE AG / BST.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BST.DE.


What is the valuation status of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to BASTEI LUBBE AG (BST.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for BASTEI LUBBE AG?

BASTEI LUBBE AG (BST.DE) has a profitability rating of 7 / 10.


What is the valuation of BASTEI LUBBE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BASTEI LUBBE AG (BST.DE) is 10.68 and the Price/Book (PB) ratio is 1.3.


How financially healthy is BASTEI LUBBE AG?

The financial health rating of BASTEI LUBBE AG (BST.DE) is 5 / 10.